Last edition
News about "T-Cell Engagers"
WuXi Biologics Signs Deal with Candid Therapeutics to Boost Trispecific T-cell Engager
Under the terms of the agreement, Candid will have exclusive global rights to a preclinical trispecific T-cell Engager discovered at WuXi Biologics' proprietary universal multispecific antibody platform WuXiBody.
T-cell Engagers | 07/01/2025 | By Aishwarya
Boehringer Ingelheim Inks Second Pact with 3T Biosciences to Develop Cancer Immunotherapies
This second research partnership with 3T builds on the successful completion of the initial research partnership announced last year by the two companies.
T-Cell Engagers | 05/01/2024 | By Manvi | 210
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy